Necrostatin-7（Cat No.:R046989）is a potent inhibitor of receptor-interacting protein kinase 1 (RIPK1), effectively blocking necroptosis—a programmed form of necrotic cell death. By selectively inhibiting RIPK1 activity, Necrostatin-7 suppresses inflammation-driven cellular damage, providing valuable insights into the molecular mechanisms underlying cell death, inflammation, and tissue injury. This compound is especially useful for investigating conditions characterized by pathological necroptosis, including ischemic injuries, neurodegeneration, inflammatory diseases, and autoimmune disorders. Consequently, Necrostatin-7 is widely employed in biomedical research to explore potential therapeutic interventions targeting necroptotic pathways in various chronic and acute disease models.